Loading clinical trials...
Loading clinical trials...
Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Compared to Standard Proteinase Inhibitors on Top of Potent Antiviral Combination Therapy
Conditions
Interventions
ATAZANAVIR
Locations
1
Switzerland
University Hospital Zurich, Infectiology
Zurich, Canton of Zurich, Switzerland
Start Date
August 1, 2004
Completion Date
May 1, 2006
Last Updated
May 27, 2009
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
Foundation for Cardiovascular Research, Zurich
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions